Relapsing Forms of Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing Forms of Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) [Phase 2]
A Phase 2 clinical trial evaluated the safety of BIIB091 and its effect on brain inflammation when taken alone or with diroximel fumarate in…
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS) [Phase 3]
Phase 3 trial of diroximel fumarate in adults with relapsing forms of multiple sclerosis in the Asia-Pacific region has completed, with resu…
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Long-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple Sclerosis [Phase 3]
Phase 3 trial update on long-term safety and tolerability of 0.5 mg fingolimod in relapsing forms of multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS
The trial update reports the effectiveness of dimethyl fumarate and its impact on patient-reported outcomes in suboptimal glatiramer acetate…
-
CLINICAL_TRIALS trial_result · 2014-11-11Clinical Trial Update: Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States [Phase 4]
Phase 4 trial evaluating the gastrointestinal tolerability of dimethyl fumarate in adults with relapsing forms of multiple sclerosis; result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.